(ALMDT) Mediantechn - Ratings and Ratios

Median Technologies SA is a global leader in the development and commercialization of innovative software solutions for medical image analysis. Specializing in advanced imaging technologies, the company provides cutting-edge tools for the diagnosis and monitoring of diseases, with a particular focus on oncology and fibrotic diseases. Its product portfolio includes iBiops, an AI-driven software as a medical device designed for early cancer detection and fibrosis assessment; iSee, a comprehensive platform for image analysis in clinical trials; and iCRO, which offers specialized imaging services for oncology clinical trials. Headquartered in Valbonne, France, the company operates across key markets including the United States, Canada, the United Kingdom, China, and other international regions.

Founded in 2002, Median Technologies has established itself as a pioneer in leveraging artificial intelligence and machine learning to enhance medical imaging workflows. Its solutions are widely used by pharmaceutical companies, research institutions, and healthcare providers to improve diagnostic accuracy, streamline clinical trials, and enable personalized medicine. The company’s commitment to innovation has positioned it at the forefront of the medical imaging sector, with a strong emphasis on addressing unmet needs in disease diagnosis and treatment monitoring.